HUTCHMED (ADR) (HCM)
Develops targeted therapies and immunotherapies, commercializing medicines in China and through global partners.
$14.22
vs last close+0.15 (+1.03%)
Something off on this page? Send us feedback.
EPSReportedEstimate
Sep '24Feb '25Mar '25Jul '25Aug '25Mar '26Jul '26Jul '26
Reported$0.03$0.04$0.07$1.35$2.60$0.00$0.05$0.05
Estimate—−$0.32$0.04−$0.32$1.46$2.50−$0.36$0.15
Surprise—+111.0%+75.0%+525.9%+78.1%−100.0%+112.8%−68.3%
RevenueReportedEstimate
Sep '24Feb '25Mar '25Jul '25Aug '25Mar '26Jul '26Jul '26
Reported$162.3M$162.3M$324.5M$138.8M$277.7M$271.0M$139.1M$278.3M
Estimate—$57.3M$319.3M$57.3M$330.4M$290.5M$80.9M$304.2M
Surprise—+183.3%+1.7%+142.4%−15.9%−6.7%+71.9%−8.5%
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Sep 2029 | $0.25 | — | — |
| Jun 2029 | $0.30 | — | — |
| Mar 2029 | $0.21 | — | — |
| Dec 2028 | $0.15 | — | — |
| Sep 2028 | $2.50 | — | — |
| Jun 2028 | $1.46 | — | — |
| Mar 2028 | $0.04 | — | — |
| Dec 2027 | −$0.39 | — | — |
| Sep 2027 | −$0.55 | — | — |
| Jun 2027 | −$0.52 | — | — |
| Mar 2027 | −$1.23 | — | — |
| Mar 2027 | $0.21 | — | — |
| Sep 2026 | −$0.34 | — | — |
| Jul 2026 | $0.15 | $0.05 | −68.3% |
| Jul 2026 | −$0.36 | $0.05 | +112.8% |
| Mar 2026 | $2.50 | $0.00 | −100.0% |
| Aug 2025 | $1.46 | $2.60 | +78.1% |
| Jul 2025 | |||
| Mar 2025 | |||
| Feb 2025 | |||
| Sep 2024 | |||
| Jul 2024 | |||
| Jun 2024 | |||
| Mar 2024 | |||
| Feb 2024 | |||
| Jul 2023 | |||
| Jun 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Aug 2022 | |||
| Mar 2022 | |||
| Sep 2021 | |||
| Jul 2021 | |||
| Jun 2021 | |||
| Mar 2021 | |||
| Sep 2020 | |||
| Jul 2020 | |||
| Mar 2020 | |||
| Sep 2019 | |||
| Jul 2019 | |||
| Mar 2019 | |||
| Sep 2018 | |||
| Jul 2018 | |||
| Mar 2018 | |||
| Jul 2017 | |||
| Mar 2017 | |||
| Sep 2016 | |||
| Aug 2016 | |||
| Mar 2016 | |||
| Sep 2015 | |||
| Jun 2015 | |||
| Mar 2015 | |||
| Dec 2014 | |||
| Sep 2014 | |||
| Jun 2014 | |||
| Mar 2014 | |||
| Dec 2013 | |||
| Sep 2013 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Sep 2029 | $0.25 | — | — | $348.9M | — | — | — |
| Jun 2029 | $0.30 | — | — | $335.1M | — | — | — |
| Mar 2029 | $0.21 | — | — | $329.1M | — | — | — |
| Dec 2028 | $0.15 | — | — | $304.2M | — | — | — |
| Sep 2028 | $2.50 | — | — | $290.5M | — | — | — |
| Jun 2028 | $1.46 | — | — | $330.4M | — | — | — |
| Mar 2028 | $0.04 | — | — | $319.3M | — | — | — |
| Dec 2027 | −$0.39 | — | — | $319.3M | — | — | — |
| Sep 2027 | −$0.55 | — | — | $318.5M | — | — | — |
| Jun 2027 | −$0.52 | — | — | $307.9M | — | — | — |
| Mar 2027 | −$1.23 | — | — | $210.0M | — | — | — |
| Mar 4, 2027 | $0.21 | — | — | $329.1M | — | — | — |
| Sep 2026 | −$0.34 | — | — | $90.7M | — | — | — |
| Jul 30, 2026 | $0.15 | $0.05 | −68.3% | $304.2M | $278.3M | −8.5% | −5.4% |
| Jul 2, 2026 | −$0.36 | $0.05 | +112.8% | $80.9M | $139.1M | +71.9% | +6.1% |
| Mar 5, 2026 | $2.50 | $0.00 | −100.0% | $290.5M | $271.0M | −6.7% | +1.5% |
| Aug 7, 2025 | $1.46 | $2.60 | +78.1% | $330.4M | $277.7M | −15.9% | −9.0% |
| Jul 2, 2025 | |||||||
| Mar 19, 2025 | |||||||
| Feb 26, 2025 | |||||||
| Sep 30, 2024 | |||||||
| Jul 31, 2024 | |||||||
| Jun 10, 2024 | |||||||
| Mar 12, 2024 | |||||||
| Feb 28, 2024 | |||||||
| Jul 31, 2023 | |||||||
| Jun 27, 2023 | |||||||
| May 30, 2023 | |||||||
| Feb 28, 2023 | |||||||
| Aug 1, 2022 | |||||||
| Mar 3, 2022 | |||||||
| Sep 30, 2021 | |||||||
| Jul 28, 2021 | |||||||
| Jun 18, 2021 | |||||||
| Mar 4, 2021 | |||||||
| Sep 30, 2020 | |||||||
| Jul 30, 2020 | |||||||
| Mar 3, 2020 | |||||||
| Sep 30, 2019 | |||||||
| Jul 30, 2019 | |||||||
| Mar 11, 2019 | |||||||
| Sep 30, 2018 | |||||||
| Jul 27, 2018 | |||||||
| Mar 12, 2018 | |||||||
| Jul 31, 2017 | |||||||
| Mar 13, 2017 | |||||||
| Sep 30, 2016 | |||||||
| Aug 2, 2016 | |||||||
| Mar 1, 2016 | |||||||
| Sep 30, 2015 | |||||||
| Jun 30, 2015 | |||||||
| Mar 31, 2015 | |||||||
| Dec 31, 2014 | |||||||
| Sep 30, 2014 | |||||||
| Jun 30, 2014 | |||||||
| Mar 31, 2014 | |||||||
| Dec 31, 2013 | |||||||
| Sep 30, 2013 |